Immunosuppressant management upon elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis patients with prior liver transplant.
作者信息
Coman Diana, Vincent Catherine, Huard Genevieve, Marleau Denis, Lavoie Annick, Hercun Julian
机构信息
Liver Unit - Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.
Respirology Unit - Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.
出版信息
J Cyst Fibros. 2024 May;23(3):561-562. doi: 10.1016/j.jcf.2023.11.004. Epub 2023 Nov 24.
PMID:38000917
Abstract
摘要
相似文献
1
Immunosuppressant management upon elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis patients with prior liver transplant.
J Cyst Fibros. 2024 May;23(3):561-562. doi: 10.1016/j.jcf.2023.11.004. Epub 2023 Nov 24.
2
Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis.
J Cyst Fibros. 2022 Jan;21(1):e8-e10. doi: 10.1016/j.jcf.2021.05.008. Epub 2021 Jun 13.
3
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants.
Pediatr Pulmonol. 2024 Jul;59(7):2009-2011. doi: 10.1002/ppul.26997. Epub 2024 Apr 12.
4
Elexacaftor/Tezacaftor/Ivacaftor therapy in cystic fibrosis children previously CFSPID: Is it over-medicalization?
J Cyst Fibros. 2024 Mar;23(2):366-367. doi: 10.1016/j.jcf.2023.10.008. Epub 2023 Oct 13.
5
Reversal of cystic bronchiectasis with elexacaftor/tezacaftor/ivacaftor.
Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.00929-2024. Print 2024 Sep.
6
Elexacaftor/Tezacaftor/Ivacaftor Effectiveness in N1303K Variant in Adult People With Cystic Fibrosis.
Arch Bronconeumol. 2024 Aug;60(8):526-528. doi: 10.1016/j.arbres.2024.04.007. Epub 2024 Apr 24.
7
Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy.
Am J Respir Crit Care Med. 2024 Aug 1;210(3):365-367. doi: 10.1164/rccm.202404-0787LE.
8
Reply to Piehler : Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy.
Am J Respir Crit Care Med. 2024 Aug 1;210(3):367. doi: 10.1164/rccm.202404-0852LE.
9
Triple Therapy for Cystic Fibrosis -Gating and -Residual Function Genotypes.
N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665.
10
Reply: Reversal of structural abnormalities with elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: the earlier you start, the better the outcome will be!
Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.01247-2024. Print 2024 Sep.
Zotero 插件